regulatory

News

Celadon gets nod to start cannabis trial for pain in UK

Celadon Pharmaceuticals has secured the final approval needed to start a large-scale trial of its cannabinoid therapy for chronic pain in the UK.

News

FDA rejects Citius' revived IL-2 therapy for lymphoma

The FDA has rejected Citius Pharmaceuticals' marketing application for Lymphir, an updated version of a lymphoma therapy withdrawn from sale several years ago.

News

Donanemab data an “important advance” in Alzheimer’s

The full data from the TRAILBLAZER-ALZ 2 trial of Eli Lilly’s amyloid drug donanemab has confirmed the top-line results reported in May, but also

News

FTC asks for more info on Pfizer’s $43bn Seagen takeover

The US Federal Trade Commission (FTC) has asked for more information on Pfizer’s $43 billion agreement to acquire Seagen before it will deliver a decision on whether the d

News

Illumina fined €432m for ignoring Grail merger objection

The European Commission has levied a substantial penalty on DNA sequencing giant Illumina for closing its takeover of cancer detection company Grail without EU regulatory

News

Takeda pulls its dengue vaccine filing from FDA

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it t

Celadon gets nod to start cannabis trial for pain in UK

FDA rejects Citius' revived IL-2 therapy for lymphoma

Donanemab data an “important advance” in Alzheimer’s

FTC asks for more info on Pfizer’s $43bn Seagen takeover

Illumina fined €432m for ignoring Grail merger objection

Takeda pulls its dengue vaccine filing from FDA

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

regulatory

Editor's Picks